| Home |
| |
Cross Atlantic Partners (CAP) actively manages private equity venture funds for investment in developing healthcare and life sciences companies in the United States. We focus on later-stage private and public companies developing innovative drug discovery tools, devices, and services for human healthcare.
Since our founding in 1994, CAP has achieved an aggregate 36.9% compound internal rate of return (IRR)
and a 2.3X cash-on-cash return on completed investments. |
|
|
|
|
|
